Lymphoma

Showing NaN - NaN of 168

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Gastrointestinal Cancer, Lymphoma, Thoracic Cancer Trial in Boston, Brighton, Methuen (SURGE, Standard of Care)

Not yet recruiting
  • Gastrointestinal Cancer
  • +2 more
  • SURGE
  • Standard of Care
  • Boston, Massachusetts
  • +2 more
May 11, 2022

Lymphoma, Survivorship Trial in Boston (Interview with Clinicians, Field Test of UPLYFT with Lymphoma Survivors, Pilot of UPLYFT

Recruiting
  • Lymphoma
  • Survivorship
  • Interview with Clinicians
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 14, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Lymphoma, Autonomic Imbalance, Cancer Survivorship Trial in Boston (Ivabradine, Placebo Oral Tablet)

Terminated
  • Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 19, 2022

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Lymphoma Trial in Worldwide (Nivolumab)

Completed
  • Lymphoma
  • Phoenix, Arizona
  • +44 more
Dec 13, 2021

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Lymphoma Trial in Worldwide (Nivolumab)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +49 more
Nov 24, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

Lymphoma Trial in Boston (3RP-Lymphoma)

Completed
  • Lymphoma
  • 3RP-Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 9, 2021

Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)

Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 28, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Solid Tumor, Adult Trial in United States (LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER,

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
Oct 11, 2021

Lymphoma Trial in Germany, Spain, United States (cemiplimab, REGN1979)

Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
Sep 20, 2021

Lymphoma Trial in Boston (Home Hospital for Lymphoma)

Withdrawn
  • Lymphoma
  • Home Hospital for Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 31, 2021

Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
Aug 16, 2021

Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
Aug 16, 2021

Solid Tumors, Lymphoma Trial in Boston, Philadelphia (PM00104)

Terminated
  • Solid Tumors
  • Lymphoma
  • Boston, Massachusetts
  • +1 more
Jul 7, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

Completed
  • Breast Carcinoma
  • +12 more
  • Management of Therapy Complications
  • +3 more
  • Los Angeles, California
  • +5 more
Oct 8, 2020